First Solar is accelerating US manufacturing expansion as trade policies create advantages for domestic production. The company faces both opportunities from protectionist measures and challenges from contract disputes.
Caterpillar’s recent 10% surge to $577.26 has investors questioning whether the industrial giant’s rally has gone too far. With concerns about weak operational performance and high valuation, analysts suggest a potential correction to $404. The infrastructure spending optimism may be masking deeper
Vertiv makes its largest strategic acquisition yet with PurgeRite, targeting the booming liquid cooling market for AI workloads. The $1 billion cash deal could reach $1.25 billion with performance incentives, representing a major consolidation in data center infrastructure services.
Lufthansa Technik’s third-quarter results reveal a complex picture of booming MRO demand hampered by US tariffs and persistent supply chain constraints. The German maintenance provider continues expanding Leap engine services while navigating economic headwinds.
A new Horizon Europe initiative is developing an integrated platform to convert organic waste and biogenic CO₂ into four distinct advanced biofuels. The project represents a crucial step toward making sustainable fuels economically viable for maritime and heavy road transport.
India is accelerating its transition from electronics assembly to component manufacturing and AI development. With $630M in PCB investments and major AI partnerships, the country aims to reshape global tech supply chains.
While political and corporate interest in reshoring US manufacturing grows, significant infrastructure, skills, and economic barriers remain. The reality is more complex than simple relocation.
Canada’s economy contracted 0.3% in August with minimal Q3 growth expected. The data reveals concerning trends across goods-producing and service sectors, suggesting deeper economic headwinds ahead.
Scientists have demonstrated superconductivity in gallium-hyperdoped germanium thin films, a breakthrough that could bridge conventional semiconductors with quantum technologies. The discovery reveals substitutional doping creates coherent superconducting-semiconducting interfaces. This development
Merck’s blockbuster cancer immunotherapy Keytruda just delivered its first $8 billion quarter, but the pharmaceutical giant faces a critical deadline. With patent protection expiring in 2028, the company is racing to cut costs and diversify beyond its flagship product.
